Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2004American Journal of Respiratory and Critical Care Medicine

Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

ENEric NuermbergerJohns Hopkins UniversityTYTetsuyuki YoshimatsuBeppu Medical CenterSTSandeep TyagiJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nuermberger et al. (2004) studied this question.

synapsesocial.com/papers/6a758b2ae42ca79ec1e725f8https://doi.org/10.1164/rccm.200407-885oc
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis2003 · 321 citations
  2. 2In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosis1998 · 184 citations
  3. 3Activity of moxifloxacin against mycobacteria1999 · 141 citations
  4. 4Rapid Assessment of Drug Susceptibilities of Mycobacterium tuberculosis by Means of Luciferase Reporter Phages1993 · 437 citations
  5. 5Five-Year Follow-Up of a Clinical Trial of Three 6-Month Regimens of Chemotherapy Given Intermittently in the Continuation Phase in the Treatment of Pulmonary Tuberculosis1988 · 53 citations